This is great news, thanks @BuffettWarren, I've recently invested in a few more companies than I usually would and this timeline went through to the keeper, thanks for your help. I like the prospects for EBR and think it will be noticed more over the course of this year and obviously go a rocket in the leadup to submission to FDA. The wait after submission during the review period usually sees even more interesting increases so I like ERB's timeline a lot. All shareholders now could be expecting multiples in the coming year
General Investor Information EBR Systems, page-256
Add EBR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.08 |
Change
0.035(3.37%) |
Mkt cap ! $331.2M | |||
| Open | High | Low | Value | Volume |
| $1.04 | $1.08 | $1.02 | $106.3K | 101.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50 | $1.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.08 | 17975 | 1 |
View Market Depth
| Last trade - 15.59pm 17/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.08 |
Change
0.035 ( 6.15 %) |
||||
| Open | High | Low | Volume | ||
| $1.03 | $1.08 | $1.02 | 46378 | ||
| Last updated 14.58pm 17/06/2024 ? | |||||
| EBR (ASX) Chart |
